Sponsors
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
Blog
Where our team of guest writers discuss what they think about the current NGP US Issues.
Director of Business Development
Can digital pathology save drug development?
Peter Duncan of Definiens discusses the potential of digital pathology.07 Jul 2010
Focus Area: Clinical Trials
EDC brings clinical development into focus
Statistics is the ultimate in fuzzy mathematics. While statistics may not actually find the needle in the haystack, by using statistics at least we know the odds of locating the needle before it's time for dinner.
Rare dedication
Sigma-Tau Pharmaceuticals specializes in discovering novel therapies for patients suffering with rare diseases. After all, this unique company is keen to stress, ‘there’s no difference between a disease that affects 300 or 300 million people’.
A successful program to engage the public
AWARE for all – clinical research education day
Companion Diagnostics for Guiding Therapy Decisions: Bridging the Gap from Development to Commercialization
David M. Johnston, Ph.D
Biomarkers: where are we and where are we going?
By J. Fred Pritchard, PhD, Malle Jurima-Romet, PhD, Lena King, PhD, DABT, and Claudio Carini, MD, PhD, FRCP(Path)
Source: www.ngpharma.com© 2010 GDS Publishing Ltd. All rights reserved.